Targeting IL-17A to combat immune-related adverse events
Nat Cancer
.
2024 Sep;5(9):1289-1291.
doi: 10.1038/s43018-024-00804-2.
Authors
Kailan Sierra-Davidson
1
,
Genevieve M Boland
2
3
Affiliations
1
Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
2
Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
[email protected]
.
3
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
[email protected]
.
PMID:
39210006
DOI:
10.1038/s43018-024-00804-2
No abstract available
Publication types
News